Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain: Current Status and Future Prospects

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.3, 2010-06, pp. : 173-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rotavirus Vaccine: Current Status and Future Prospects

By Bernstein D.I.

BioDrugs, Vol. 14, Iss. 5, 2000-11 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Gene Therapy for Muscular Dystrophies: Current Status and Future Prospects

By Takeda S. Miyagoe-Suzuki Y.

BioDrugs, Vol. 15, Iss. 10, 2001-10 ,pp. : 635-644

Adis International

Access to resources Recommend Favorite

Gene Therapy for Rheumatoid Arthritis: Current Status and Future Prospects

By Fabre Sylvie Apparailly Florence

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 381-391

Adis International

Access to resources Recommend Favorite

Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects

By Rice G.P.A.

BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 267-277

Adis International

Access to resources Recommend Favorite

Treatment of Cutaneous T Cell Lymphoma: Current Status and Future Directions

By Apisarnthanarax N. Talpur R. Duvic M.

American Journal of Clinical Dermatology, Vol. 3, Iss. 3, 2002-03 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite